Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-ASC-SHEET in Diabetic Foot Ulcers
NCT03754465Phase 2Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- Jan 2019
- Primary completion
- Oct 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allo-asc in diabetic foot ulcer (DFU), sponsored by Anterogen Co., Ltd.. Started Jan 2019; status: completed.
02
Drugs
allo-asc
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03754465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754465.